LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,577,814 | -12.6% | 797,645 | -10.2% | 0.01% | -16.7% |
| Q2 2023 | $61,323,630 | +196.6% | 888,362 | +107.2% | 0.01% | +200.0% |
| Q1 2023 | $20,674,422 | +56.1% | 428,752 | +61.6% | 0.00% | 0.0% |
| Q4 2022 | $13,244,575 | +35.3% | 265,316 | +10.6% | 0.00% | +100.0% |
| Q3 2022 | $9,791,000 | +16.4% | 239,978 | +56.9% | 0.00% | 0.0% |
| Q2 2022 | $8,413,000 | +70.8% | 152,965 | +12.9% | 0.00% | 0.0% |
| Q1 2022 | $4,926,000 | -32.7% | 135,538 | -13.7% | 0.00% | 0.0% |
| Q4 2021 | $7,319,000 | -23.5% | 157,023 | -17.0% | 0.00% | 0.0% |
| Q3 2021 | $9,571,000 | +304.0% | 189,291 | +228.0% | 0.00% | – |
| Q2 2021 | $2,369,000 | +71.7% | 57,707 | +21.4% | 0.00% | – |
| Q1 2021 | $1,380,000 | -56.8% | 47,546 | -58.1% | 0.00% | – |
| Q4 2020 | $3,195,000 | +337.1% | 113,465 | +379.1% | 0.00% | – |
| Q3 2020 | $731,000 | -42.1% | 23,681 | -20.2% | 0.00% | – |
| Q2 2020 | $1,262,000 | – | 29,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |